<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8"/>
    <title>ETTA Biotechnology</title>
    <meta name="description" content="Evidence-based Treatments Targeted Aging"/>
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0"/>
    <link rel="icon" type="image/png" href="imgs/etta-logo.png"/>
    <script src="./bundle.js" type="text/javascript" defer></script>
    <script>
      (function (w, d, s, l, i) {
        w[l] = w[l] || []
        w[l].push({
          'gtm.start':
            new Date().getTime(), event: 'gtm.js'
        })
        var f = d.getElementsByTagName(s)[0],
          j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''
        j.async = true
        j.src =
          'https://www.googletagmanager.com/gtm.js?id=' + i + dl
        f.parentNode.insertBefore(j, f)
      })(window, document, 'script', 'dataLayer', 'GTM-PT46K5C')
    </script>
</head>

<body>
<!-- Google Tag Manager (noscript) -->
<noscript>
    <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PT46K5C"
            height="0" width="0" style="display:none;visibility:hidden"></iframe>
</noscript>
<!-- End Google Tag Manager (noscript) -->
<header class="c-head">
    <div class="container c-head__container">
        <div class="c-head__brand">
            <a href="/"><img src="imgs/etta.png" alt="ETTA" width="127" height="35"
                             class="c-head__img"></a>
        </div>

        <a href="#" class="c-head__mobile js-head-mobile">
            <span class="c-head__icon"></span>
            <span class="h-sr-only">Navigation</span>
        </a>

        <nav class="c-head__nav">
            <ul class="c-head__links">
                <li><a href="/" class="c-head__link">HOME</a>
                </li>
                <li><a href="/about.html" class="c-head__link">ABOUT US</a></li>
                <li><a href="/science.html" class="c-head__link">THE SCIENCE</a></li>
                <li><a href="/pipeline.html" class="c-head__link">PIPELINE</a></li>
                <li><a href="/about.html#contact" class="c-head__link">CONTACT US</a></li>
            </ul>
        </nav>
    </div>
</header>
<div class="container-fluid hero">
    <div class="bg-container">
        <img alt="" src="/imgs/cells.jpg"/>
    </div>
    <div class="bg-text large mobile-large">
        AGING THERAPEUTICS
    </div>
</div>
<div class="container after-hero">
    
<img class="image-fit" src="/imgs/Fisetin.PNG"/>

<p><br/>Senescent cell removal, insulin signaling inhibition/caloric restriction, and rapamycin (mTOR inhibition) extend lifespan in mice the most in our meta-analysis of over 100 different aging interventions. Surprisingly, the natural molecule fisetin can do all three, offering great promise as a therapeutic. </p>
    
   

    <p>
        References:<br/>
        [1] Yousefzadeh MJ, Zhu Y, Mcgowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28.<br/>
        [2] Adhami VM, Syed DN, Khan N, Mukhtar H. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem Pharmacol. 2012;84(10):1277-81.<br/>
        [3] <a href="https://clinicaltrials.gov/ct2/results?cond=&term=fisetin"
               target="_blank">https://clinicaltrials.gov/ct2/results?cond=&term=fisetin</a><br/>
        [4] Chamcheu JC, Esnault S, Adhami VM, et al. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019;8(9).<br/>
        [5] Kim GD, Lee SE, Park YS, Shin DH, Park GG, Park CS. Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice. Food Chem Toxicol. 2014;66:341-9.<br/>
        [6] Wu PY, Lyu JL, Liu YJ, et al. Fisetin Regulates Nrf2 Expression and the Inflammation-Related Signaling Pathway to Prevent UVB-Induced Skin Damage in Hairless Mice. Int J Mol Sci. 2017;18(10).<br/>
        [7] Sechi M, Lall RK, Afolabi SO, et al. Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models. Sci Rep. 2018;8(1):15726.
    </p>
</div>

<div class="container-fluid hero" id="nano">
    <div class="bg-container">
        <img alt="" src="/imgs/nano-1.jpg"/>
    </div>
    <div class="bg-text">
        NANO-TECHNOLOGY
    </div>
</div>

<div class="container after-hero">
    
</div>

<div class="container section">
    <div class="flex">
        <div class="flex flex-column h-text-center">
            <div class="nano-chip-image">
                <img alt="" class="image-fit image-height-fit" src="/imgs/nano-microspy.jpg"/>
            </div>
            <p>Transmission Electron Microscopy Image</p>
        </div>
        <div class="flex flex-column">
            <p><br/><br/><br/><b>Magnetic nanoparticles (MNP)</b> can serve as a vehicle after coating to conduct targeted delivery of
                <b>dissolved fisetin</b> to improve <b>bioavailability</b>.</p>
            <div class="flex flex-row h-text-center">
                <div class="seno-item column">
                    <div class="logo"><img class="image-fit" src="/imgs/nano-mnp-2.jpg"/></div>
                    <div>
                        <h3>Thermal Release Nanoparticles</h3>
                    </div>
                </div>
                <div class="seno-item column">
                    <div class="logo"><img class="image-fit" src="/imgs/nano-mnp-1.jpg"/></div>
                    <div>
                        <h3>PEGylated Nanoparticles</h3>
                    </div>
                </div>
                <div class="seno-item column">
                    <div class="logo"><img class="image-fit" src="/imgs/nano-mnp-3.jpg"/></div>
                    <div>
                        <h3>Porous Nanoparticles</h3>
                    </div>
                </div>
            </div>
        </div>
    </div>
<p>Fisetin has low bioavailability and is quickly cleared from the body, limiting its effectiveness. Due to its excellent safety profile, clinical trials using large doses of fisetin are currently underway in hopes it can help in human aging despite these drawbacks. At ETTA, we are trying a better way. Our proprietary metal core nanoparticles can deliver fisetin, as well as other small molecules, RNA, DNA, and proteins, to treat a wide range of diseases.</p>
  <p>
        References:<br/>
        [1] https://clinicaltrials.gov/ct2/results?cond=&term=fisetin<br/>
    </p>


</div>

  



<div class="footer-region">
    <div class="bg-container">
        <img alt="" src="/imgs/index-footer.jpg"/>
    </div>
    <div class="footer-wrapper">
        <div class="footer-container">
            <div class="footer-column footer-column-4 footer-basis-250">
                <div class="footer-col-heading"><a href="https://ettabiotechnology.com" target="_blank"><img
                        src='/imgs/etta.png' alt='ETTA'/></a></div>
                <div class="footer-col-item">Â© 2020 ETTA Biotechnology, All rights reserved.</div>
                <div class="footer-col-item">San Francisco, CA <br/>United States</div>
            </div>
            <div class="footer-column footer-column-1">
                <div class="footer-col-heading">Social</div>
                <div class="footer-col-item"><a href='https://www.linkedin.com/company/ettabiotechnology'
                                                target="_blank">LinkedIn</a></div>
                <div class="footer-col-item"><a href='https://medium.com/etta-biotechnology' target="_blank">Medium</a>
                </div>
                <div class="footer-col-item"><a href='https://twitter.com/ETTABiotechnol1' target="_blank">Twitter</a>
                </div>
            </div>
        </div>
    </div>
</div>


</body>
</html>
